adrenomedullin and Pneumonia--Ventilator-Associated

adrenomedullin has been researched along with Pneumonia--Ventilator-Associated* in 2 studies

Other Studies

2 other study(ies) available for adrenomedullin and Pneumonia--Ventilator-Associated

ArticleYear
Prognostic Role of Serum Adrenomedullin in Patients with Ventilator Associated Pneumonia.
    Advances in respiratory medicine, 2022, Aug-18, Volume: 90, Issue:4

    Ventilator associated pneumonia is a common type of sepsis that occurs to about 9-27% of all mechanically ventilated patients and 20-50% of them develop septic shock. Several clinical, laboratory, and radiological methods have been used for diagnosing VAP. Adrenomedullin (ADM) has been found to be elevated in the plasma of septic patients. The study aim was to explore the prognostic role of ADM in the VAP patients.. A prospective observational study.. Intensive Care Department of Alexandria University Hospitals.. A total of 140 patients with proven VAP after medical ICU admission were consecutively enrolled.. APACHE II score, SOFA score, CRP, lactate, and serum ADM were measured at day 0 of VAP diagnosis and 5 days later. The results were correlated with the outcomes of patients.. APACHE II, lactate, and serum ADM on day 0 could predict an unfavorable outcome. ADM prediction power was significantly higher than APACHE II and lactate. Day 5 readings of all tested parameters could predict occurrence of the unfavorable outcome. ADM on day 0 showed the highest sensitivity (96.25%).. Serum adrenomedullin when measured at days 0 and 5 of VAP diagnosis may serve as an early predictor of unfavorable outcome.

    Topics: Adrenomedullin; APACHE; Humans; Lactates; Pneumonia, Ventilator-Associated; Prognosis

2022
Biomarkers kinetics in the assessment of ventilator-associated pneumonia response to antibiotics - results from the BioVAP study.
    Journal of critical care, 2017, Volume: 41

    Our aim was to evaluate the role of biomarker kinetics in the assessment of ventilator-associated pneumonia (VAP) response to antibiotics.. We performed a prospective, multicenter, observational study to evaluate in 37 microbiologically documented VAP, the kinetics of C-reactive protein (CRP), procalcitonin (PCT), mid-region fragment of pro-adrenomedullin (MR-proADM). The kinetics of each variable, from day 1 to 6 of therapy, was assessed with a time dependent analysis comparing survivors and non-survivors.. During the study period kinetics of CRP as well as its relative changes, CRP-ratio, was significantly different between survivors and non-survivors (p=0.026 and p=0.005, respectively). On day 4 of antibiotic therapy, CRP of survivors was 47% of the initial value while it was 96% in non-survivors. The kinetics of other studied variables did not distinguish between survivors and non-survivors. In survivors the bacterial load also decreased markedly. Adequate initial antibiotic therapy was associated with lower mortality (p=0.025) and faster CRP decrease (p=0.029).. C-reactive protein kinetics can be used to identify VAP patients with poor outcome as soon as four days after the initiation of treatment. (Trial registration - NCT02078999; registered 3 August 2012).

    Topics: Adrenomedullin; Adult; Aged; Analysis of Variance; Anti-Bacterial Agents; Bacterial Load; Biomarkers; C-Reactive Protein; Calcitonin; Female; Humans; Male; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Protein Precursors; Trachea

2017